Results
92
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
92 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.38 | -0.9% | -0.9% | SEK 373.7m | SEK 2.20 | PS3.2x | E86.1% | n/a | Tech | ||
CALTX | SEK 206.80 | -0.1% | 125.4% | SEK 11.2b | SEK 227.50 | PS7x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
YUBICO | SEK 281.00 | -9.4% | 183.8% | SEK 24.2b | SEK 296.67 | PE124.9x | E42.5% | n/a | Software | ||
MAGLE | SEK 38.60 | 2.7% | 24.5% | SEK 416.9m | SEK 50.00 | PE54.2x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
TRUE B | SEK 35.72 | -2.5% | 3.3% | SEK 12.3b | SEK 57.20 | PE25.8x | E21.6% | 1.1% | Software | ||
CTT | SEK 284.00 | -0.7% | 23.5% | SEK 3.6b | n/a | PE34.9x | E24.8% | 1.9% | Capital Goods | ||
FNOX | SEK 58.46 | 1.6% | 4.9% | SEK 35.7b | SEK 77.88 | PE54.9x | E22.6% | 0.3% | Software | ||
BIOA B | SEK 166.50 | 3.2% | -47.5% | SEK 14.7b | SEK 290.60 | PS48.7x | E99.1% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.66 | 2.3% | -70.3% | SEK 223.2m | SEK 7.90 | PS30.6x | E73.1% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.20 | -1.3% | -23.9% | SEK 237.9m | SEK 2.84 | PS2.2x | E115.5% | n/a | Tech | ||
ORGC | SEK 2.94 | -5.2% | -25.9% | SEK 288.5m | SEK 3.00 | PS2.1x | E109.0% | n/a | Materials | ||
CRAD B | SEK 43.50 | -0.1% | 41.0% | SEK 1.5b | SEK 57.00 | PE27.3x | E33.9% | n/a | Healthcare | ||
ESGR B | SEK 29.65 | -0.8% | -56.4% | SEK 195.3m | SEK 58.00 | PS1.1x | E56.6% | n/a | Household | ||
CTM | SEK 7.27 | -1.5% | -59.5% | SEK 550.0m | SEK 29.70 | PB0.3x | E123.9% | 0% | Media | ||
FLEXQ | SEK 11.00 | 0% | -36.8% | SEK 147.4m | SEK 25.00 | PS1.3x | E118.7% | n/a | Capital Goods | ||
EQT | SEK 342.80 | -1.6% | 55.5% | SEK 405.0b | SEK 354.83 | PE118.5x | E35.9% | 1.0% | Diversified Financials | ||
4C | SEK 16.20 | -9.2% | -35.2% | SEK 569.1m | SEK 22.00 | PS1.9x | E108.0% | n/a | Software | ||
SENZA | SEK 7.70 | 2.0% | -5.9% | SEK 227.2m | SEK 16.00 | PS4.1x | E109.9% | n/a | Pharmaceuticals & Biotech | ||
KLAR | SEK 0.45 | -6.6% | -28.6% | SEK 58.4m | SEK 1.00 | PB2.8x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
EGTX | SEK 5.80 | 1.4% | 37.1% | SEK 1.7b | SEK 11.40 | PS24x | E90.0% | n/a | Pharmaceuticals & Biotech | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods | ||
TENEO | SEK 0.45 | -6.6% | -50.4% | SEK 168.7m | n/a | PS1.8x | E66.8% | n/a | Software | ||
LIME | SEK 332.50 | -3.6% | 25.9% | SEK 4.4b | SEK 353.33 | PE51.4x | E24.1% | 1.1% | Software | ||
RAIL | SEK 29.40 | 1.4% | 62.0% | SEK 709.3m | SEK 34.00 | PE16.2x | E27.0% | 2.4% | Transportation |